Literature DB >> 12948706

Attenuation correction of PET activation studies in the presence of task-related motion.

Odile A van den Heuvel1, Ronald Boellaard, Dick J Veltman, Catalina Mesina, Adriaan A Lammertsma.   

Abstract

Motion-induced misalignment between transmission and emission scans can result in erroneous estimation of regional tissue activity concentrations. If this motion is of a random nature, mismatch between transmission and emission scans is likely to result in diminished signal-to-noise ratios. In the case of task-related motion, however, corresponding systematic reconstruction artefacts may lead to false-positive or false-negative results. The purpose of the present study was to investigate whether implementation of an image registration (IR) method, which allows for motion-corrected attenuation correction, would improve accuracy of H(2)(15)O PET activation studies. To evaluate the performance of this method, phantom studies as well as studies in human subjects were performed. Results were compared with three alternative methods: standard attenuation correction without motion correction, calculated attenuation correction, and no attenuation correction. The phantom measurements showed that, for quantitative assessment of regional activity concentrations, the IR method was superior to the other attenuation correction methods. In a single-subject study with intentional task-related motion during a visual stimulation paradigm, false-positive results, obtained with the standard attenuation correction method, disappeared after attenuation correction using the IR method. Finally, a group analysis of 11 patients indicated that an increase in signal-to-noise ratio was obtained with the IR method. Therefore, in our view, the IR method should be considered as a first choice for attenuation correction in PET activation studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948706     DOI: 10.1016/s1053-8119(03)00216-7

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  4 in total

1.  Increased neural efficiency in the temporal association cortex as the result of semantic task repetition.

Authors:  Christine Whatmough; Jim Nikelski; Oury Monchi; Howard Chertkow
Journal:  Hum Brain Mapp       Date:  2008-08       Impact factor: 5.038

2.  Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study.

Authors:  Martin Nørgaard; Melanie Ganz; Claus Svarer; Vibe G Frokjaer; Douglas N Greve; Stephen C Strother; Gitte M Knudsen
Journal:  Neuroimage       Date:  2019-06-01       Impact factor: 6.556

3.  Cerebral serotonin transporter measurements with [11C]DASB: A review on acquisition and preprocessing across 21 PET centres.

Authors:  Martin Nørgaard; Melanie Ganz; Claus Svarer; Ling Feng; Masanori Ichise; Rupert Lanzenberger; Mark Lubberink; Ramin V Parsey; Marios Politis; Eugenii A Rabiner; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; Peter S Talbot; Federico Turkheimer; Stephen C Strother; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-13       Impact factor: 6.200

4.  Guidelines for the content and format of PET brain data in publications and archives: A consensus paper.

Authors:  Gitte M Knudsen; Melanie Ganz; Stefan Appelhoff; Ronald Boellaard; Guy Bormans; Richard E Carson; Ciprian Catana; Doris Doudet; Antony D Gee; Douglas N Greve; Roger N Gunn; Christer Halldin; Peter Herscovitch; Henry Huang; Sune H Keller; Adriaan A Lammertsma; Rupert Lanzenberger; Jeih-San Liow; Talakad G Lohith; Mark Lubberink; Chul H Lyoo; J John Mann; Granville J Matheson; Thomas E Nichols; Martin Nørgaard; Todd Ogden; Ramin Parsey; Victor W Pike; Julie Price; Gaia Rizzo; Pedro Rosa-Neto; Martin Schain; Peter Jh Scott; Graham Searle; Mark Slifstein; Tetsuya Suhara; Peter S Talbot; Adam Thomas; Mattia Veronese; Dean F Wong; Maqsood Yaqub; Francesca Zanderigo; Sami Zoghbi; Robert B Innis
Journal:  J Cereb Blood Flow Metab       Date:  2020-02-16       Impact factor: 6.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.